PPARG and endometrial cancer: Furthermore, Koyama et al. treated the endometrial cancer cell lines HHUA, Ishikawa, and HEC-59, with the PPARγ ligand telmisartan, which exerted potent growth inhibitory and apoptotic effects in all three studied cancer cell lines.